REFERENCES
- Brainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, Rollag MD. (2001). Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J. Neurosci. 21:6405–6412.
- Davis S, Mirick DK, Stevens RG. (2001). Night shift work, light at night, and risk of breast cancer. J. Natl. Cancer Inst. 93:1557–1562.
- Gooley JJ, Chamberlain K, Smith KA, Khalsa SB, Rajaratnam SM, Van Reen E, Zeitzer JM, Czeisler CA, Lockley SW. (2011). Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J. Clin. Endocrinol. Metab. 96:463–72.
- Hätönen T, Alila-Johansson A, Mustanoja S, Laakso ML. (1999). Suppression of melatonin by 2000-lux light in humans with closed eyelids. Biol. Psychiatry 46:827–831.
- Kloog I, Portnov BA, Rennert HS, Haim A. (2011). Does the modern urbanized sleeping habitat pose a breast cancer risk? Chronobiol. Int. 28:76–80.
- Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP. (1980). Light suppresses melatonin secretion in humans. Science 210:1267–1269.
- Li Q, Zheng T, Holford TR, Boyle P, Zhang Y, Dai M. (2010). Light at night and breast cancer: results from a population-based case-control study in Connecticut, USA. Cancer Causes Control 21:2281–2285.
- O'Leary ES, Schoenfeld ER, Stevens RG, Kabat GC, Henderson K, Grimson R, Gammon MD, Leske MC, Electromagnetic Fields and Breast Cancer on Long Island Study Group. (2006). Shift work, light at night, and breast cancer on Long Island, New York. Am. J. Epidemiol. 164:358–366.
- Rennert G, Pinchev M, Rennert HS. (2010). Use of bisphosphonates and risk of postmenopausal breast cancer. J. Clin. Oncol. 28:3577–3581.
- Wehr TA. (1992). In short photoperiods, human sleep is biphasic. J. Sleep Res. 1:103–107.
- Zubidat AE, Randy J, Nelson RJ, Haim A. (2010). Photoentrainment in blind and sighted rodent species: responses to photophase light with different wavelengths. J. Exp. Biol. 213:4213–4222.